Kevin Feeley - 29 Apr 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Bridget Brown, Attorney-in-Fact
Issuer symbol: WGS
Transactions as of: 29 Apr 2025
Net transactions value: -$20,013
Form type: 4
Filing time: 01 May 2025, 19:46:17 UTC
Previous filing: 09 May 2025
Next filing: 03 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	WGS	Class A Common Stock	Options Exercise	$0	+753	+25%	$0.000000	3,725	29 Apr 2025	Direct	F1
transaction	WGS	Class A Common Stock	Sale	$43,879	-388	-10%	$113.09	3,337	29 Apr 2025	Direct	F2
transaction	WGS	Class A Common Stock	Award	$23,865	+420	+13%	$56.82	3,757	30 Apr 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	WGS	Restricted Stock Unit	Options Exercise	$0	-753	-20%	$0.000000	3,014	29 Apr 2025	Class A Common Stock	753		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3	These shares were acquired under the Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F4	25% of the total RSUs vest on April 29, 2023 and April 29, 2024, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested on April 29, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date.